Evidence map›Paper›PMID 30345125›Full record

ArticleCase reports in hematology2018

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation.

Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Tyrosine kinase inhibitors and interferon-α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Håkon ReikvamSection for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-5439-8411
Jørn SkavlandSection for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
Stein-Erik GullaksenSection for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
Randi HovlandDepartment for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Tobias Gedde-DahlSection for Hematology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Øystein BruserudSection for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-7892-4367
Bjørn Tore GjertsenSection for Hematology, Institute of Clinical Science, University of Bergen, Bergen, Norway.
Haukeland University Hospital · NOUniversity of Bergen · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein

Identifiers

PMID30345125
PMCPMC6174736
OpenAlexW2893904358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.